Lung Injury Associated with Bortezomib Therapy in Relapsed/Refractory Multiple Myeloma in Japan: A Questionnaire-Based Report from the "Lung Injury by Bortezomib" Joint Committee of the Japanese Society of Hematology and the Japanese Society of Clinical Hematology-Reference-Cited by-同舟云学术

Lung Injury Associated with Bortezomib Therapy in Relapsed/Refractory Multiple Myeloma in Japan: A Questionnaire-Based Report from the "Lung Injury by Bortezomib" Joint Committee of the Japanese Society of Hematology and the Japanese Society of Clinical Hematology

Published:2006-12-01 Issue:5 Volume:84 Page:406-412
ISSN:0925-5710
Container-title:International Journal of Hematology
language:
Short-container-title:International Journal of Hematology

Author:

Gotoh Akihiko,Ohyashiki Kazuma,Oshimi Kazuo,Usui Noriko,Hotta Tomomitsu,Dan Kazuo,Ikeda Yasuo

Publisher

Springer Science and Business Media LLC

Subject

Hematology

Link

http://www.springerlink.com/index/pdf/10.1532/IJH97.06142

Reference17 articles.

1. Bross PF, Kane R, Farrell AT, et al. Approval summary for bortezomib for injection in the treatment of multiple myeloma. Clin Cancer Res. 2004; 10:3954-3964.

2. Jagannath S, Durie BG, Wolf J, et al. Bortezomib therapy alone and in combination with dexamethasone for previously untreated symptomatic multiple myeloma. Br J Haematol. 2005; 129:776-783.

3. Richardson PG, Barlogie B, Berenson J, et al. A phase 2 study of bortezomib in relapsed, refractory myeloma. N Engl J Med. 2003; 348:2609-2617.

4. Jagannath S, Barlogie B, Berenson J, et al. A phase 2 study of two doses of bortezomib in relapsed or refractory myeloma. Br J Haematol. 2004; 127:165-172.

5. Miyakoshi S, Kami M, Yuji K, et al. Severe pulmonary complications in Japanese patients after bortezomib treatment for refractory multiple myeloma. Blood. 2006; 107:3492-3494.

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proteasome Inhibitor (Bortezomib);Analysis File of Drug-Induced Lung Injury;2024

2. Pembrolizumab plus lenalidomide and dexamethasone in treatment-naive multiple myeloma (KEYNOTE-185): subgroup analysis in Japanese patients;International Journal of Hematology;2020-09-19

3. Severe but reversible pulmonary hypertension in scleromyxedema and multiple myeloma: a case report;BMC Pulmonary Medicine;2020-01-09

4. Bortezomib-induced diffuse alveolar hemorrhage in a patient with plasma cell leukemia;Respiratory Medicine Case Reports;2020

5. Bortezomib-Induced Pulmonary Toxicity: A Case Report and Review of Literature;Case Reports in Medicine;2018-11-25